Danaher Corporation (NYSE: DHR), a leading science and technology services provider in the U.S., has entered into a partnership with the Chongqing Liang Jiang New Area government to establish the Danaher Western Innovation Center in the district. This new center, located adjacent to the Children’s Hospital of Chongqing Medical University, is designed to be a hub of multiple functions including biopharmaceutical talent development, innovation incubation, product R&D, customer service, technical support, application development, functional verification, and collaborative office spaces.
Danaher plans to establish a life sciences research institute in the region, marking its third in China after similar institutes in Shanghai and Guangzhou. Additionally, Cytiva, a Danaher company, will set up a western science and technology innovation center in the area. These two centers aim to become open innovation platforms, focusing on spatial omics, genomics, multi-omics innovation research, clinical efficacy evaluation, and cutting-edge fields such as organoids, cell therapy, synthetic biology, and nucleic acid drug processes. The initiative is expected to foster industry exchanges and accelerate the innovation and high-quality development of local biopharmaceutical research and production.- Flcube.com
